The Reference Range Lie
The standard laboratory reference range for total testosterone in adult men spans approximately 264 to 916 ng/dL. This range is derived from population statistics that include men of all ages, body compositions, and health statuses. It includes the 80-year-old with diabetes and the 25-year-old athlete. It includes the obese, the chronically stressed, the metabolically dysfunctional, and the healthy. The resulting range is so broad that it is clinically useless for determining whether an individual man's testosterone level is adequate for his age and health goals.
A 38-year-old man presenting with fatigue, low libido, difficulty building muscle, brain fog, irritability, and weight gain around the midsection receives a total testosterone result of 310 ng/dL. His doctor tells him his testosterone is normal because it falls within the reference range. The conversation ends. No treatment is offered. The member leaves believing that his symptoms are due to aging, stress, or lifestyle rather than a measurable hormonal deficiency that is affecting every aspect of his physical and mental function.
The reference range is not an optimal range. It is a statistical distribution of a sick population. Labeling a 38-year-old with 310 ng/dL as normal because an 85-year-old with the same level exists in the reference population is not medicine. It is statistical sleight of hand that leaves millions of men symptomatic and untreated.
At Kure Health, we distinguish between the population reference range and the functional optimal range. Optimal total testosterone for men under 50 seeking full metabolic, cognitive, sexual, and physical function is 600 to 900 ng/dL. Below 500 in a symptomatic man warrants investigation and potential intervention. Below 400 in any man under 50 represents significant deficiency regardless of what the lab printout says.
What "Normal" Actually Means vs. What It Should Mean
The concept of normal in laboratory medicine is statistical, not clinical. A value is normal if it falls within two standard deviations of the population mean. This means that by definition, the tested population typically falls within the normal range. It does not mean that everyone within that range is healthy or functioning optimally. It means they are statistically common.
Population testosterone levels have declined approximately 1 percent per year since the 1980s. A man with a total testosterone of 400 ng/dL today would have been in the lower range in 1985. Today he is solidly mid-range because the entire population has shifted downward. The reference range adjusts to the declining population, normalizing a trend that reflects worsening metabolic health, increasing obesity, rising environmental toxin burden, and chronic stress rather than representing biological adequacy.
The symptoms of suboptimal testosterone do not wait for a laboratory cutoff to appear. Men with total testosterone between 300 and 500 ng/dL frequently experience fatigue, reduced motivation, decreased libido, difficulty maintaining muscle mass, increased body fat, cognitive slowing, irritability, and sleep disruption. These symptoms reduce quality of life, impair professional performance, and strain relationships. Telling these men they are normal because they exceed an arbitrary statistical threshold is failing them clinically.
Optimal is not a single number. It is the level at which symptoms resolve and function is restored. For most men, this falls between 600 and 900 ng/dL for total testosterone, with free testosterone in the upper quartile of the age-appropriate range. The goal of treatment is not a lab value. It is the resolution of symptoms and the restoration of function.
Free vs. Total: The Number Your Doctor Ignores
Total testosterone measures all testosterone in the bloodstream: free, albumin-bound, and SHBG-bound. Only free testosterone and, to a lesser extent, albumin-bound testosterone are biologically available to enter cells and activate androgen receptors. SHBG-bound testosterone is tightly sequestered and unavailable for biological activity. A man can have adequate total testosterone and critically low free testosterone if his SHBG is elevated.
SHBG, sex hormone-binding globulin, increases with age, hyperthyroidism, liver disease, estrogen elevation, and certain medications. As SHBG rises, it binds more testosterone, reducing the free fraction that is available to produce biological effects. A man with total testosterone of 550 and an SHBG of 80 may have a free testosterone equivalent to a man with total testosterone of 300 and normal SHBG. The total number looks acceptable. The bioavailable amount is deficient.
Most primary care physicians and even many endocrinologists test only total testosterone. When it falls within the reference range, no further investigation occurs. The free testosterone that determines actual biological effect at the cellular level is not measured. The member is told his testosterone is fine while his cells are testosterone-starved because the majority of his circulating testosterone is bound and unavailable.
Testing: Total testosterone, free testosterone, and SHBG must be evaluated together. Bioavailable testosterone can be calculated from these values. At Kure Health, the hormonal assessment also includes estradiol, which reveals whether aromatase conversion is reducing testosterone and increasing estrogen, LH and FSH which reveal whether the deficiency is testicular or pituitary in origin, and DHEA-S which evaluates adrenal androgen production.
Why Testosterone Is Declining: It Is Not Just Aging
Population-level testosterone decline of approximately 1 percent per year since the 1980s cannot be explained by aging alone because the decline persists when researchers control for age. A 45-year-old man today has significantly lower testosterone than a 45-year-old man in 1987, independent of body composition differences. Something in the modern environment is driving testosterone downward across the entire male population.
Endocrine-disrupting chemicals are the primary suspects. BPA, phthalates, PFAS, pesticides, and other environmental chemicals have documented anti-androgenic and estrogenic effects. They interfere with testosterone synthesis in Leydig cells, increase aromatase activity converting testosterone to estrogen, and disrupt the hypothalamic-pituitary-gonadal axis signaling that regulates testosterone production. The cumulative exposure from plastics, processed food packaging, personal care products, and contaminated water creates a persistent anti-androgenic environment.
Obesity and insulin resistance compound the decline. Adipose tissue expresses aromatase, converting testosterone to estradiol. Insulin resistance impairs LH signaling to the testes, reducing testosterone production. Sleep deprivation, increasingly prevalent in modern society, directly suppresses testosterone production: men sleeping 5 hours produce 10 to 15 percent less testosterone than those sleeping 7 to 8 hours. Chronic psychological stress elevates cortisol, which directly suppresses GnRH and LH, reducing testicular testosterone output.
The Signal-Based perspective recognizes that low testosterone in a modern man is rarely a simple testicular failure. It is the downstream consequence of multiple upstream disruptions: environmental toxin burden, metabolic dysfunction, sleep deprivation, and chronic stress. Addressing these upstream drivers often improves testosterone production naturally, and when replacement is indicated, treating the drivers prevents the ongoing suppression that would otherwise undermine the therapy.
The Signal-Based Approach to Optimization
Testosterone optimization at Kure Health begins with the VITAL Index, not a prescription pad. Before any consideration of exogenous testosterone, the complete picture must be evaluated: what is the total and free testosterone, why is it low, and what upstream factors are driving the deficiency? The treatment plan addresses the cause, not just the number.
Metabolic optimization is the foundation. Insulin resistance suppresses testosterone production and increases aromatase conversion. Correcting insulin sensitivity through dietary modification, targeted supplementation, and exercise programming often produces measurable testosterone improvement within 8 to 12 weeks. Sleep optimization is prescribed, not suggested: every hour of sleep below 7 hours costs approximately a portion of testosterone production. Stress management through HPA axis rehabilitation reduces the cortisol-mediated suppression of the HPG axis.
When exogenous testosterone is indicated, the delivery method is selected based on individual physiology and preference. Options include weekly intramuscular injections for the most consistent levels, transdermal creams for daily application, and subcutaneous pellet therapy for steady-state delivery lasting 4 to 6 months. Estradiol is monitored because aromatase conversion of exogenous testosterone can worsen estrogen dominance. An aromatase inhibitor is added only when estradiol elevation is documented, not prophylactically.
Monitoring is ongoing and comprehensive. Total and free testosterone, SHBG, estradiol, hematocrit, PSA, and metabolic markers are evaluated at regular intervals. The goal is symptom resolution with hormone levels in the optimal range, not maximum dosing. At Kure Health, testosterone optimization is one component of a comprehensive protocol that addresses every metabolic signal contributing to the member's symptoms. The hormone is important. The system it operates within is what determines the outcome.
Frequently Asked Questions
What is a good testosterone level for a man? Optimal total testosterone for men under 50 is 600 to 900 ng/dL. The standard reference range starts at 264, which prevents severe deficiency disease but does not represent functional adequacy. Free testosterone must also be evaluated alongside SHBG.
What are symptoms of low testosterone? Fatigue, low libido, difficulty building muscle, increased body fat especially midsection, brain fog, irritability, poor sleep, decreased motivation, and erectile changes. These symptoms commonly appear below 500 ng/dL total testosterone or with low free testosterone.
Why is testosterone declining in men? Environmental endocrine disruptors (BPA, phthalates, PFAS), increasing obesity and insulin resistance, chronic sleep deprivation, and sustained stress are driving population-level decline of approximately 1 percent per year since the 1980s.
Should I get testosterone replacement therapy? First evaluate why testosterone is low: insulin resistance, sleep deprivation, stress, and environmental toxins should be addressed. When metabolic optimization is insufficient and symptoms persist, monitored TRT with estradiol tracking is appropriate.
